JOHNSON & JOHNSON 8-K

What Happened
Johnson & Johnson announced its sales and earnings for the fiscal fourth quarter and full year ended December 28, 2025 and filed a Form 8-K on January 21, 2026 (Item 2.02). The filing attaches a press release and unaudited supplementary sales data and a condensed consolidated statement of earnings for the periods reported. The report was signed by Robert J. Decker, Jr., Controller (Principal Accounting Officer).

Key Details

• Filing date: January 21, 2026 (Current Report on Form 8-K).
• Period covered: fourth quarter and full year ended December 28, 2025.
• Exhibits included: 99.1 (press release dated Jan 21, 2026) and 99.2 (unaudited comparative supplementary sales data and condensed consolidated statement of earnings).
• Report signed by Robert J. Decker, Jr., Controller.

Why It Matters
This 8-K makes J&J’s reported quarterly and annual sales and earnings publicly available; investors should review the attached press release and supplementary data to see revenue, earnings (EPS), segment performance, and any management commentary. Quarterly and full‑year results are primary indicators of company health and can affect stock price, analyst estimates, and investment decisions.